Moreover, researchers from this same group showed the effect of an EGFR tyrosine kinase inhibitor (AG1478) alone and in combination with cisplatin on two vulvar cancer cells lines, and the growth inhibition was depending on EGFR expression, by inhibition of the activity of EGFR, AKT, ERK. Here, EGFR is linked to vulva cancer.